Delivery Order SPE2DB20D3303-SPE2DB25FA2LR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,595.37 to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets in 30-count units. This competitively awarded, firm fixed price delivery order was finalized on June 20, 2025, with an ultimate completion date of June 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 200 mg tablets (30-count units) on August 26, 2025, with a ceiling value of $1,004.61. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate completion date for this delivery order is August 27,...
- The Defense Logistics Agency has awarded a delivery order valued at $1,638.18 to AmerisourceBergen Drug Corp for the supply of Lamotrigine ER 250 mg tablets in quantities of 30 units. The contract is structured as a firm fixed price delivery order with an ultimate completion date of June 2, 2025. This award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $1,129.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Lamotrigine 25 mg dispersible tablets (100-count units). The contract is classified as a non-set-aside competitive award with an ultimate completion date of May 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,336.23 to AmerisourceBergen Drug Corp for Lamotrigine ER 300 mg tablets (30-count supply) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used to treat epilepsy and bipolar...
- The Defense Logistics Agency awarded a delivery order valued at $4,824.31 to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets (30-count) on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lamotrigine is a neurological medication commonly used for seizure management and bipolar...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 50 mg tablets in quantities of 30 units, with a ceiling value of $4,276.80. The contract was competitively awarded without set-aside designation under a firm fixed-price arrangement, with an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the place of performance for this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Lamotrigine ER 100 mg tablets in quantities of 30 units, with a ceiling value of $1,163.95. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lamotrigine ER 200 mg tablets in a 30-count package, with a ceiling value of $1,516.80 and a firm fixed price structure. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime contract vehicle valued through December 2026 that provides...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lamotrigine ODT 100 mg tablets (30-unit quantity) under a firm fixed-price contract valued at $11,986.07. This non-set-aside competitive award represents a single delivery order for this generic neurological medication, with an ultimate completion date of September 11, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA2LRDelivery Order
The Defense Logistics Agency awarded a $3,943.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lamotrigine ER 250 mg tablets (30-count units), with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. The pharmaceutical product being delivered—Lamotrigine ER—is a neurological medication commonly used in military and federal healthcare settings. This delivery order exemplifies the company's extensive portfolio of federal medical supply contracts, which encompass a broad range of therapeutic domains from specialty medications to vaccines and medical devices, all delivered under firm fixed-price terms to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 8/12/25 |